ICOS and non-small cell lung carcinoma: Patients with low expression of ICOS had a more advanced level of T stage NSCLC compared with patients with high expression of ICOS (p < 0.001, Table 1), and the same result was shown for clinicopathological stage (p = 0.004, Table 1).